Doximity, Inc. Files 8-K for Other Events
Ticker: DOCS · Form: 8-K · Filed: Dec 30, 2025 · CIK: 1516513
| Field | Detail |
|---|---|
| Company | Doximity, Inc. (DOCS) |
| Form Type | 8-K |
| Filed Date | Dec 30, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001, $31 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events
Related Tickers: DOCS
TL;DR
DOX filed an 8-K for 'Other Events' on 12/24/25.
AI Summary
Doximity, Inc. filed an 8-K on December 30, 2025, reporting an event that occurred on December 24, 2025. The filing is categorized under 'Other Events' and pertains to the company's operations as of December 24, 2025. Doximity, Inc. is incorporated in Delaware and its principal executive offices are located in San Francisco, California.
Why It Matters
This filing indicates a material event has occurred for Doximity, Inc. that requires public disclosure, though the specific nature of the event is not detailed in the provided header information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' without immediate indication of significant financial or operational changes.
Key Numbers
- 001-40508 — SEC File Number (Identifies Doximity's filing with the SEC)
- 27-2485512 — EIN (Employer Identification Number for Doximity, Inc.)
Key Players & Entities
- Doximity, Inc. (company) — Registrant
- December 24, 2025 (date) — Date of earliest event reported
- December 30, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 500 3rd St. Suite 510 San Francisco, CA 94107 (address) — Principal executive offices
FAQ
What specific event is Doximity, Inc. reporting under 'Other Events'?
The provided header information does not specify the exact nature of the 'Other Events' being reported; it only indicates the date of the event (December 24, 2025) and the filing date (December 30, 2025).
When was this 8-K form filed with the SEC?
The 8-K form was filed on December 30, 2025.
What is the exact name of the company filing this report?
The exact name of the registrant is Doximity, Inc.
In which state is Doximity, Inc. incorporated?
Doximity, Inc. is incorporated in Delaware.
What is the address of Doximity, Inc.'s principal executive offices?
The address of Doximity, Inc.'s principal executive offices is 500 3rd St. Suite 510 San Francisco, CA 94107.
Filing Stats: 840 words · 3 min read · ~3 pages · Grade level 13.2 · Accepted 2025-12-30 16:01:19
Key Financial Figures
- $0.001 — which registered Class A common stock, $0.001 par value per share DOCS The New York S
- $31 m — for an aggregate settlement payment of $31 million, which will be fully funded by in
Filing Documents
- docs-20251224.htm (8-K) — 25KB
- 0001516513-25-000114.txt ( ) — 140KB
- docs-20251224.xsd (EX-101.SCH) — 2KB
- docs-20251224_lab.xml (EX-101.LAB) — 22KB
- docs-20251224_pre.xml (EX-101.PRE) — 13KB
- docs-20251224_htm.xml (XML) — 3KB
01 - Other Events
Item 8.01 - Other Events As previously reported, Doximity, Inc. ("Doximity" or the "Company") and certain company directors and officers have been named as defendants in a securities litigation lawsuit ("Securities Litigation") pending in the United States District Court for the Northern District of California, captioned In re Doximity, Inc. Securities Litigation, No. 5:24-cv-02281 (N.D. Cal.). On December 24, 2025, the parties entered into an Agreement of Settlement (the "Settlement"), that, if approved by the court and if all conditions are satisfied, will resolve the Securities Litigation. The Settlement provides for an aggregate settlement payment of $31 million, which will be fully funded by insurance proceeds. The Settlement includes the dismissal of all claims against the Company and the named individuals without any admission of liability, fault or wrongdoing attributed to them. The Settlement remains subject to stockholder notice, court approval and other customary conditions. Use of Forward-Looking Statements This current report contains "forward-looking statements", as defined in the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements, include, without limitation, (i) the Settlement resolving the Securities Litigation; (ii) the ability to secure the approval of the proposed settlement from the court and to satisfy all conditions in the proposed settlement; and (iii) other statements that are not historical facts, and instead constitute forward-looking statements. These and other future events are subject to substantial risk, uncertainties, and other factors, many which are beyond the Company's control and cause actual results to differ materially from those indicated by forward-looking statements, favorably or unfavorably. These risks and uncertainties include, without limitation, (a) the Settlement not having the expected impact, including resolving the Securities Litigation; (b) the proposed settlem
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 30, 2025 DOXIMITY, INC. By: /s/ John Vaughan John Vaughan General Counsel and Corporate Secretary